Correction to: “Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors” - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to: “Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors”

  • January 22, 2026

Share

Objective:

To correct the author list in the previously published article.

Key Findings:
  • Correction of author name from 'Julia García' to 'Julia García-Arabehety'.
Interpretation:

The correction ensures proper attribution of authorship in the published research.

Limitations:
Conclusion:

The article has been corrected online to reflect the accurate author name.

Original Source(s)

Correction to: “Validation and Limitations of the PANOMEN-3 Predictive Model for Tumor Recurrence and Progression in Pituitary Tumors”

  • January 22, 2026

Related Content

Medical Oddities: Dogs share our mortality markers

The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

Ovulation may shift preferences toward conspicuous luxury

Across 3 studies, higher fertility was associated with greater preference for luxury when it was visible, personally relevant, and potentially noticeable to others.

Tirzepatide’s cardiovascular effects in clinical practice

Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.